Pulike Biological Engineering, Inc.

SSE:603566.SS

14.73 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 278.619280.82278.59243.667231.546324.149313.963308.936305.645402.307313.003267.414245.292277.549241.788270.546308.685281.078225.676228.601193.157192.255151.357172.274147.309177.099145.67141.47143.821148.78122.847126.039132.229156.31177.05133.196116.546116.412138.3693.754129.613105.354157.39889.13123.808
Cost of Revenue 112.248124.902102.843108.74883.808132.471120.941109.618125.367151.215112.52100.03193.574111.37381.24989.43797.89111.74475.84274.72568.93786.19359.00662.08750.35362.17946.73145.86145.4652.04439.20339.05537.53646.90645.45540.8434.11237.32236.43627.43129.21531.2736.76351.11225.556
Gross Profit 166.372155.917175.747134.92147.738191.678193.022199.318180.278251.092200.483167.383151.718166.176160.539181.109210.795169.334149.834153.877124.219106.06292.351110.18796.956114.9298.9495.60998.36196.73783.64486.98494.693109.404131.59592.35682.43479.09101.92366.323100.39774.084120.63538.01898.252
Gross Profit Ratio 0.5970.5550.6310.5540.6380.5910.6150.6450.590.6240.6410.6260.6190.5990.6640.6690.6830.6020.6640.6730.6430.5520.610.640.6580.6490.6790.6760.6840.650.6810.690.7160.70.7430.6930.7070.6790.7370.7070.7750.7030.7660.4270.794
Reseach & Development Expenses 20.91837.0526.0418.16820.4639.93722.07821.95917.12243.16823.7297.75515.80325.31720.68519.68719.88428.36645.18824.43616.84731.21114.20413.27932.12132.27213.93215.3911.86625.96913.80121.439058.461025.216041.765018.313036.87309.6799.679
General & Administrative Expenses 18.952-50.20572.402-22.51434.27-31.43350.05-5.17916.309-31.67951.981-6.80422.461-21.72541.648-7.00218.696-21.89717.452-3.27215.387-19.15913.261-5.25714.78-24.86114.164-10.92525.917-39.48533.415-3.48927.021-31.28628.45-8.71326.667-30.66720.63919.81820.48-28.72619.62720.71420.714
Selling & Marketing Expenses 62.0813.575111.1770.96363.40499.14889.40487.09876.38125.81593.47380.27565.13995.89367.33570.2866.5372.17258.35447.56232.90854.08434.69635.97339.84250.06233.30430.27533.47245.44434.69731.56631.55541.78433.12129.84626.28727.89428.20822.94828.3626.53728.45725.9425.94
SG&A 81.033-46.629183.57171.38297.29367.715139.45481.91992.6994.136145.45573.47187.674.169108.98363.27985.22750.27575.80744.2948.29534.92647.95730.71654.62225.20147.46819.3559.3895.9668.11228.07658.57610.49861.57121.13252.954-2.77248.84742.76648.84-2.18948.08447.00347.003
Other Expenses 2.529183.289-69.072-0.793-0.121-15.69620.899-20.4-0.20861.685-30.4724.9022.2051.8166.45212.251-0.13735.2731.854-6.3824.35510.2791.0381.5075.418.0446.60.181.7356.15116.6670.3272.2964.4095.3315.09823.0832.1883.8951.8736.3241.7651.041-16.792-80.113
Operating Expenses 104.48173.71140.53990.343117.753173.996137.052126.439109.603198.989138.714106.128105.607126.619107.699104.253107.245119.499111.7379.07862.587104.08160.61857.03486.6297.42561.95960.84860.05879.9770.29561.33560.4581.2362.43653.11453.59957.5649.56843.2949.52351.84848.877-16.792-80.113
Operating Income 61.891-17.79335.20744.57729.985-5.39966.46655.23676.71137.39953.99750.24141.57241.38564.776.684101.81562.09446.46875.3462.6858.58933.13954.30610.8516.60542.43445.07342.62423.10517.54531.04936.19335.29470.03148.44629.2827.40950.59226.65749.64524.8467.84521.22643.695
Operating Income Ratio 0.222-0.0630.1260.1830.13-0.0170.2120.1790.2510.0930.1730.1880.1690.1490.2680.2830.330.2210.2060.330.3250.0450.2190.3150.0740.0370.2910.3190.2960.1550.1430.2460.2740.2260.3960.3640.2510.2350.3660.2840.3830.2360.4310.2380.353
Total Other Income Expenses Net 0.32-0.5591.3191.609-0.1211.025-2.4241.60.3593.184.092-0.156-0.019-18.9755.68912.073-0.13711.3321.854-4.1244.3552.3474.881.5075.418.0446.60.1011.73513.33715.8890.8982.0314.355.3315.08723.0832.1543.8841.8656.3241.561.0415.5551.272
Income Before Tax 62.211-18.35236.52653.16631.649-4.37467.09255.10876.78639.00353.37250.08541.55322.4170.38989.698101.67873.42648.32271.21667.0410.93634.17755.81216.26114.64949.03445.17444.35929.32434.17231.37638.46139.64475.36253.53352.36329.56354.47628.53655.96926.468.88526.78144.967
Income Before Tax Ratio 0.223-0.0650.1310.2180.137-0.0130.2140.1780.2510.0970.1710.1870.1690.0810.2910.3320.3290.2610.2140.3120.3470.0570.2260.3240.110.0830.3370.3190.3080.1970.2780.2490.2910.2540.4260.4020.4490.2540.3940.3040.4320.2510.4380.30.363
Income Tax Expense 9.304-4.8872.9244.1633.7580.2195.4793.07111.326-2.2590.7797.3494.038.9023.36212.94514.8296.1547.87710.597.64-3.244.1845.1541.842-1.8766.3797.2915.8087.5613.6882.815.0897.859.3467.0928.6124.9997.9344.639.238-8.61316.61691.306-72.619
Net Income 52.908-13.46632.32646.63927.307-4.59461.61452.03864.03941.26252.59342.73637.52313.50867.02876.75386.84967.27240.44560.62659.40114.17729.99350.65914.41816.52542.65537.88338.55121.76330.48428.56733.37231.79466.01646.44143.75124.56446.54223.90346.73335.01352.2715.50137.473
Net Income Ratio 0.19-0.0480.1160.1910.118-0.0140.1960.1680.210.1030.1680.160.1530.0490.2770.2840.2810.2390.1790.2650.3080.0740.1980.2940.0980.0930.2930.2680.2680.1460.2480.2270.2520.2030.3730.3490.3750.2110.3360.2550.3610.3320.3320.1740.303
EPS 0.16-0.0390.0940.140.079-0.0130.180.150.190.120.170.140.120.0430.220.250.280.220.130.180.180.0430.0930.140.040.0460.130.120.120.0680.0940.0860.10.10.210.140.140.0770.150.10.20.150.220.0640.16
EPS Diluted 0.16-0.0390.0940.140.079-0.0130.180.150.190.120.170.140.120.0430.220.250.280.220.130.180.180.0430.0930.140.040.0460.130.120.120.0680.0940.0860.10.10.210.140.140.0770.150.10.20.150.220.0640.16
EBITDA 62.322-13.61930.682.00652.56548.404105.41879.04998.59262.26358.58567.10557.32645.54485.314103.375117.78491.39958.43484.8379.58627.62731.73369.22610.33544.53436.98136.02941.27516.76714.84225.6536.37528.17471.65739.24230.31321.5355.508-55.175129.61322.23679.077-58.799123.808
EBITDA Ratio 0.224-0.0480.110.3370.2270.1490.3360.2560.3230.1550.1870.2510.2340.1640.3530.3820.3820.3250.2590.3710.4120.1440.210.4020.070.2510.2540.2550.2870.1130.1210.2040.2750.180.4050.2950.260.1850.401-0.58910.2110.502-0.661